SRGAP2C
SLIT-ROBO Rho GTPase-activating protein 2C
Also known as: SRG2C_HUMAN, SRGAP2P1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DJJ0
- Gene
- SRGAP2C
- Ensembl
- ENSG00000171943
- Chromosome
- 1
- Canonical length
- 459 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Centrosome,Basal body,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This locus encodes a member of the SLIT-ROBO Rho GTPase activating protein family. This human-specific locus resulted from segmental duplication of the SLIT-ROBO Rho GTPase activating protein 2B locus. The encoded protein lacks the GTPase activating protein domain compared to proteins encoded by SLIT-ROBO Rho GTPase activating protein 2, and acts antagonistically to these proteins in cortical neuron development. [provided by RefSeq, Dec 2012]
Canonical amino-acid sequenceUniProt
459 residues, UniProt reviewed canonical sequence.
>P0DJJ0|SRGAP2C
1 MTSPAKFKKD KEIIAEYDTQ VKEIRAQLTE QMKCLDQQCE LRVQLLQDLQ DFFRKKAEIE
61 MDYSRNLEKL AEHFLAKTRS TKDQQFKKDQ NVLSPVNCWN LLLNQVKWES RDHTTLSDIY
121 LNNIIPRFVQ VSEDSGRLFK KSKEVGQQLQ DDLMKVLNEL YSVMKTYHMY NADSISAQSK
181 LKEAEKQEEK QIGKSVKQED RQTPCSPDST ANVRIEEKHV RRSSVKKIEK MKEKHQAKYT
241 ENKLKAIKAQ NEYLLALEAT NASVFKYYIH DLSDLIDQCC DLGYHASLNR ALRTFLSAEL
301 NLEQSKHEGL DAIENAVENL DATSDKQRLM EMYNNVFCPP MKFEFQPHMG DMASQLCAQQ
361 PVQSELVQRC QQLQSRLSTL KIENEEVKKT MEATLQTIQD IVTVEDFDVS DCFQYSNSME
421 SVKSTVSETF MSKPSIAKRR ANQQETEQFY FTVRECYGFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRGAP2C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 34 nTPM
- spinal cord: 17 nTPM
- skin: 15 nTPM
- parathyroid gland: 13 nTPM
- hippocampal formation: 10 nTPM
- spleen: 9.8 nTPM
Single-cell type
- podocytes: 746 nCPM
- macrophages: 102 nCPM
- kupffer cells: 83 nCPM
- cdc: 71 nCPM
- mesothelial cells: 70 nCPM
- lymphatic endothelial cells: 64 nCPM
Immune cell
- non-classical monocyte: 4.6 nTPM
- classical monocyte: 3 nTPM
- neutrophil: 2.8 nTPM
- intermediate monocyte: 2.3 nTPM
- myeloid DC: 2.2 nTPM
- plasmacytoid DC: 2.1 nTPM
Brain region
- cerebellum: 75 nTPM
- white matter: 52 nTPM
- pons: 47 nTPM
- spinal cord: 45 nTPM
- medulla oblongata: 44 nTPM
- cerebral cortex: 38 nTPM
OntologyGO
Biological processes
- cerebral cortex development
- excitatory synapse assembly
- extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration
- inhibitory synapse assembly
- negative regulation of cell migration
- negative regulation of dendritic spine development
- negative regulation of filopodium assembly
- nervous system development
- positive regulation of neuron migration
- regulation of synapse assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRGAP2C as an antibody target. Whether an autoantibody or antibody against SRGAP2C could matter depends on whether native SRGAP2C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRGAP2C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRGAP2C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...